US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 10.710
  • +0.070+0.66%
Close Dec 23 16:00 ET
  • 10.710
  • 0.0000.00%
Post 16:01 ET
451.96MMarket Cap-3.55P/E (TTM)

UroGen Pharma Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.92%-27.66M
-17.14%-23.75M
-22.97%-31.74M
12.77%-76.38M
40.25%-13M
1.78%-17.3M
16.22%-20.27M
-7.55%-25.81M
-3.14%-87.56M
-8.38%-21.75M
Net income from continuing operations
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Operating gains losses
12.52%3.07M
7.43%3.34M
-9.54%2.6M
-17.87%11.5M
-6.63%2.79M
2.71%2.73M
-23.61%3.11M
-33.01%2.87M
-5.66%14.01M
-52.31%2.99M
Depreciation and amortization
-35.90%266K
-38.98%263K
-19.31%351K
-6.16%1.71M
-5.78%424K
-4.60%415K
-9.45%431K
-4.61%435K
2.48%1.82M
-0.22%450K
Other non cash items
-366.67%-592K
-37.18%223K
-337.87%-961K
-61.36%1.01M
-96.46%33K
-78.32%222K
-8.03%355K
43.26%404K
--2.62M
--932K
Change In working capital
-767.68%-9.15M
231.98%2.57M
-223.99%-4.01M
152.90%3.34M
866.07%7.57M
-154.89%-1.06M
63.86%-1.95M
65.90%-1.24M
55.85%-6.31M
120.50%784K
-Change in receivables
-302.67%-5.39M
-8.13%-3.26M
509.00%1.29M
-177.51%-2.74M
20.73%-2.6M
22.71%2.66M
-43.70%-3.01M
-90.49%211K
78.87%-987K
16.75%-3.28M
-Change in inventory
-985.71%-152K
-141.72%-199K
-37.72%-1.57M
-272.38%-1.35M
-337.10%-671K
91.52%-14K
185.79%477K
-1,600.00%-1.14M
87.38%-362K
127.64%283K
-Change in prepaid assets
44.34%-1.85M
-197.57%-1.72M
79.90%-210K
122.61%820K
1,202.87%5.76M
-2,170.55%-3.32M
50.17%-577K
41.94%-1.05M
11.80%-3.63M
61.67%-522K
-Change in payables and accrued expense
-112.49%-1.89M
593.95%7.46M
-398.72%-4.21M
322.14%6.71M
9.83%5.12M
-198.23%-889K
26,975.00%1.08M
135.49%1.41M
361.51%1.59M
223.99%4.66M
-Change in other current assets
-60.50%303K
23.55%425K
323.28%940K
155.32%702K
104.46%12K
237.95%767K
225.09%344K
-149.11%-421K
-24.41%-1.27M
-148.64%-269K
-Change in other current liabilities
29.77%-184K
22.62%-195K
1.98%-247K
50.91%-811K
51.09%-45K
7.09%-262K
80.51%-252K
-1,780.00%-252K
-64.54%-1.65M
-118.22%-92K
-Change in other working capital
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-59.92%-27.66M
-17.14%-23.75M
-22.97%-31.74M
12.77%-76.38M
40.25%-13M
1.78%-17.3M
16.22%-20.27M
-7.55%-25.81M
-3.14%-87.56M
-8.38%-21.75M
Investing cash flow
Cash flow from continuing investing activities
-26,720.95%-106.75M
222.53%12M
115.60%13.52M
-189.91%-953K
-149.09%-11.34M
101.13%401K
2,563.58%3.72M
-53.88%6.27M
-73.95%1.06M
153.24%23.11M
Net PPE purchase and sale
4.00%-96K
-460.00%-84K
--0
23.62%-194K
-330.77%-56K
34.64%-100K
76.19%-15K
8.00%-23K
66.22%-254K
93.56%-13K
Net investment purchase and sale
-21,388.22%-106.65M
223.48%12.08M
114.81%13.52M
-157.76%-759K
-148.82%-11.29M
101.42%501K
4,344.32%3.74M
-53.80%6.29M
-72.74%1.31M
147.89%23.12M
Cash from discontinued investing activities
Investing cash flow
-26,720.95%-106.75M
222.53%12M
115.60%13.52M
-189.91%-953K
-149.09%-11.34M
101.13%401K
2,563.58%3.72M
-53.88%6.27M
-73.95%1.06M
153.24%23.11M
Financing cash flow
Cash flow from continuing financing activities
-65.88%39.61M
70,029.37%100.29M
8,045.60%54.66M
20.38%116.93M
-99.84%40K
10,442.87%116.08M
285.71%143K
-99.05%671K
34.31%97.13M
79,375.00%25.37M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
--95.78M
--24.99M
Net common stock issuance
-77.73%15M
--81.51M
--54.66M
--67.36M
--0
--67.36M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-99.76%115K
13,030.07%18.78M
--0
3,180.81%49.57M
-89.42%40K
4,261.59%48.72M
793.75%143K
--671K
2,377.05%1.51M
--378K
Net other financing activities
----
----
----
----
----
----
----
----
-100.22%-160K
--0
Cash from discontinued financing activities
Financing cash flow
-65.88%39.61M
70,029.37%100.29M
8,045.60%54.66M
20.38%116.93M
-99.84%40K
10,442.87%116.08M
285.71%143K
-99.05%671K
34.31%97.13M
79,375.00%25.37M
Net cash flow
Beginning cash position
954.28%220.8M
254.08%132.26M
70.44%95.82M
23.33%56.22M
307.22%120.12M
-74.30%20.94M
-64.74%37.35M
23.32%56.22M
-15.72%45.59M
-47.85%29.5M
Current changes in cash
-195.59%-94.81M
639.49%88.54M
293.15%36.44M
272.37%39.6M
-190.93%-24.3M
290.71%99.18M
32.82%-16.41M
-131.27%-18.87M
225.06%10.64M
343.45%26.72M
End cash Position
4.88%125.99M
954.28%220.8M
254.08%132.26M
70.44%95.82M
70.44%95.82M
307.22%120.12M
-74.30%20.94M
-64.74%37.35M
23.33%56.22M
23.33%56.22M
Free cash flow
-59.55%-27.76M
-17.46%-23.83M
-22.86%-31.74M
12.80%-76.57M
40.03%-13.05M
2.06%-17.4M
16.38%-20.29M
-7.53%-25.83M
-2.53%-87.81M
-7.36%-21.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.92%-27.66M-17.14%-23.75M-22.97%-31.74M12.77%-76.38M40.25%-13M1.78%-17.3M16.22%-20.27M-7.55%-25.81M-3.14%-87.56M-8.38%-21.75M
Net income from continuing operations -8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M
Operating gains losses 12.52%3.07M7.43%3.34M-9.54%2.6M-17.87%11.5M-6.63%2.79M2.71%2.73M-23.61%3.11M-33.01%2.87M-5.66%14.01M-52.31%2.99M
Depreciation and amortization -35.90%266K-38.98%263K-19.31%351K-6.16%1.71M-5.78%424K-4.60%415K-9.45%431K-4.61%435K2.48%1.82M-0.22%450K
Other non cash items -366.67%-592K-37.18%223K-337.87%-961K-61.36%1.01M-96.46%33K-78.32%222K-8.03%355K43.26%404K--2.62M--932K
Change In working capital -767.68%-9.15M231.98%2.57M-223.99%-4.01M152.90%3.34M866.07%7.57M-154.89%-1.06M63.86%-1.95M65.90%-1.24M55.85%-6.31M120.50%784K
-Change in receivables -302.67%-5.39M-8.13%-3.26M509.00%1.29M-177.51%-2.74M20.73%-2.6M22.71%2.66M-43.70%-3.01M-90.49%211K78.87%-987K16.75%-3.28M
-Change in inventory -985.71%-152K-141.72%-199K-37.72%-1.57M-272.38%-1.35M-337.10%-671K91.52%-14K185.79%477K-1,600.00%-1.14M87.38%-362K127.64%283K
-Change in prepaid assets 44.34%-1.85M-197.57%-1.72M79.90%-210K122.61%820K1,202.87%5.76M-2,170.55%-3.32M50.17%-577K41.94%-1.05M11.80%-3.63M61.67%-522K
-Change in payables and accrued expense -112.49%-1.89M593.95%7.46M-398.72%-4.21M322.14%6.71M9.83%5.12M-198.23%-889K26,975.00%1.08M135.49%1.41M361.51%1.59M223.99%4.66M
-Change in other current assets -60.50%303K23.55%425K323.28%940K155.32%702K104.46%12K237.95%767K225.09%344K-149.11%-421K-24.41%-1.27M-148.64%-269K
-Change in other current liabilities 29.77%-184K22.62%-195K1.98%-247K50.91%-811K51.09%-45K7.09%-262K80.51%-252K-1,780.00%-252K-64.54%-1.65M-118.22%-92K
-Change in other working capital --0------------------------------------
Cash from discontinued investing activities
Operating cash flow -59.92%-27.66M-17.14%-23.75M-22.97%-31.74M12.77%-76.38M40.25%-13M1.78%-17.3M16.22%-20.27M-7.55%-25.81M-3.14%-87.56M-8.38%-21.75M
Investing cash flow
Cash flow from continuing investing activities -26,720.95%-106.75M222.53%12M115.60%13.52M-189.91%-953K-149.09%-11.34M101.13%401K2,563.58%3.72M-53.88%6.27M-73.95%1.06M153.24%23.11M
Net PPE purchase and sale 4.00%-96K-460.00%-84K--023.62%-194K-330.77%-56K34.64%-100K76.19%-15K8.00%-23K66.22%-254K93.56%-13K
Net investment purchase and sale -21,388.22%-106.65M223.48%12.08M114.81%13.52M-157.76%-759K-148.82%-11.29M101.42%501K4,344.32%3.74M-53.80%6.29M-72.74%1.31M147.89%23.12M
Cash from discontinued investing activities
Investing cash flow -26,720.95%-106.75M222.53%12M115.60%13.52M-189.91%-953K-149.09%-11.34M101.13%401K2,563.58%3.72M-53.88%6.27M-73.95%1.06M153.24%23.11M
Financing cash flow
Cash flow from continuing financing activities -65.88%39.61M70,029.37%100.29M8,045.60%54.66M20.38%116.93M-99.84%40K10,442.87%116.08M285.71%143K-99.05%671K34.31%97.13M79,375.00%25.37M
Net issuance payments of debt --------------0--0--------------95.78M--24.99M
Net common stock issuance -77.73%15M--81.51M--54.66M--67.36M--0--67.36M--0--0--0--0
Proceeds from stock option exercised by employees -99.76%115K13,030.07%18.78M--03,180.81%49.57M-89.42%40K4,261.59%48.72M793.75%143K--671K2,377.05%1.51M--378K
Net other financing activities ---------------------------------100.22%-160K--0
Cash from discontinued financing activities
Financing cash flow -65.88%39.61M70,029.37%100.29M8,045.60%54.66M20.38%116.93M-99.84%40K10,442.87%116.08M285.71%143K-99.05%671K34.31%97.13M79,375.00%25.37M
Net cash flow
Beginning cash position 954.28%220.8M254.08%132.26M70.44%95.82M23.33%56.22M307.22%120.12M-74.30%20.94M-64.74%37.35M23.32%56.22M-15.72%45.59M-47.85%29.5M
Current changes in cash -195.59%-94.81M639.49%88.54M293.15%36.44M272.37%39.6M-190.93%-24.3M290.71%99.18M32.82%-16.41M-131.27%-18.87M225.06%10.64M343.45%26.72M
End cash Position 4.88%125.99M954.28%220.8M254.08%132.26M70.44%95.82M70.44%95.82M307.22%120.12M-74.30%20.94M-64.74%37.35M23.33%56.22M23.33%56.22M
Free cash flow -59.55%-27.76M-17.46%-23.83M-22.86%-31.74M12.80%-76.57M40.03%-13.05M2.06%-17.4M16.38%-20.29M-7.53%-25.83M-2.53%-87.81M-7.36%-21.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.